---

Moncef Slaoui

Chairman of Vaccines, GlaxoSmithKline

Moncef was professor of immunology at the University of Mons, Belgium before his move into industry. He has published more than 100 scientific papers and is a member of the PhRMA Foundation Board of Directors. Moncef has been at the helm of GSK’s global vaccines business through its integration of the Novartis vaccine acquisition in 2015.

---

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016